Erythropeitin woes

The makers of Aranesp, an erythropoeitin stimulating agent has come out with a website advising patients to fight back and get back the Medicare to cover for treatment for anemia.

I wonder what will the patients do now if their RBC comes falling down! What a mess this is

Erythropoietin in ovarian cancer

Apparently it has now been shown that ovarian cancer cells become quite resistant to paclitaxel, if they are injected with erythropeitin. This is important because this is the first time it has been shown that erythropoeitin can induce cancer cells to become resistant to chemotherapy.

I suspect that more cancer cell lines also have this effect.